Inozyme Pharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inozyme Pharma and other ETFs, options, and stocks.

About INZY

Inozyme Pharma engages in the research and development of novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue, and skeleton. Its lead product candidate is INZ-701, which is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. 

CEO
Axel Bolte
CEOAxel Bolte
Employees
50
Employees50
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2015
Founded2015
Employees
50
Employees50

INZY Key Statistics

Market cap
112.61M
Market cap112.61M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
80.63K
Average volume80.63K
High today
$2.82
High today$2.82
Low today
$2.57
Low today$2.57
Open price
$2.57
Open price$2.57
Volume
24.38K
Volume24.38K
52 Week high
$11.09
52 Week high$11.09
52 Week low
$2.30
52 Week low$2.30

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

INZY Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.